You are here
Captor Capital: A Hidden Gem Growing Quickly in the Attractive Cannabis Sector -- CFN Media
SEATTLE, Aug. 30, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, announces publication of an article discussing Captor Capital Corp. (CSE: CPTR) (FFT: NMV) (OTC: NWURF). The company has already established a strong footprint in California’s market following its under-the-radar acquisition spree. Investors may want to take a closer look at the stock given management’s proven ability to execute deals and the potential to continue growing its presence in California (as well as outside the state) over the coming years.
California’s cannabis industry is projected to surpass $5 billion in annual revenue by next year, according to Arcview Market Research and BDS Analytics, following the legalization of recreational cannabis earlier this year. With nearly 40 million residents, the state represents about a third of the North American cannabis market, making it the largest single market on the continent, and a key area of focus for investors in the space.
Quietly Building a Statewide Brand
Captor Capital is focused on acquiring established cannabis businesses with significant existing revenue that require capital to scale. By following that model, Captor has acquired three dispensaries in key markets across California. Management plans to continue building this network of retail dispensaries to take advantage of the state’s burgeoning industry and ultimately deliver significant value to shareholders over the long-run.
The company recently acquired several cash-generating cannabis dispensaries:
- MedMen Santa Ana - An 8,148 sq. ft. facility that’s centrally located in Santa Ana, CA — the only city in Orange County, population over 3 million, to allow dispensaries. This location generated about $1.1 million in revenue in Q1 2018, the first few months of full legalization.
- MedMen West Hollywood - A 2,010 sq. ft. facility located in West Hollywood, CA, which represents about 10 percent of the Los Angeles cannabis market. The dispensary brought in about $6.4 million in revenue for Q1 2018.
- CHAI - Capitola Healing Association Inc., or CHAI, generated $9 million in revenue for the past three years and was purchased for just $6.1 million. It’s consistently ranked as a top-five dispensary in Santa Cruz, CA, with a large glassware showroom and lab-tested, 100% indoor grown product.
The MedMen-branded dispensaries are particularly appealing given MedMen’s prominence within the industry. As the behind-the-scenes owner of two high-profile dispensaries, the company provides investors with great exposure to the growing brand and two of California’s most popular recreational dispensaries. Based on California’s reported tax revenues, and MedMen’s recent unaudited revenue numbers, MedMen’s stores are outperforming the average dispensary by about 3X revenue.
MedMen figures its stores are, on average, higher grossing per square foot than Apple or Tiffany & Co. stores.
The company is also in the process of acquiring Mellow Extracts and Castroville in California, and owns equity in Fine Detail Greenway, Cascadia Gardens, and Mainstem in Washington State’s market. These new subsidiaries and investments could add millions of dollars in additional revenue, while helping build out a wider distribution footprint in both California and other emerging cannabis markets throughout the country.
Strong Growth, Compelling Value
Captor Capital expects its revenue to grow from just over $8 million in Q1’18 to about $15 million by Q2’19, while EBITDA is projected to reach nearly $4 million by Q2’19, according to its investor presentation. These figures would make it one of the largest retail dispensary networks in the entire state of California, and one of the few cannabis companies that’s actually executing on plans and moving forward with commercialization within the state.
Despite its strong performance, the little publicized company trades at a fraction of other publicly-traded companies operating in the cannabis space, based on its enterprise value-to-LTM sales, which might be due to the low profile the company keeps. Many Canadian licensed producers trade at multiples greater than 100x, while Captor Capital trades at a valuation of less than 10x EV-to-LTM Sales, making it a potentially undervalued opportunity for investors interested in the cannabis space.
Investors have an opportunity to benefit from the best of both worlds: A top-performing company within California’s burgeoning cannabis market and a potentially undervalued stock within the larger cannabis industry.
Captor Capital Corp. (CSE: CPTR) has built an established network of retail dispensaries across California, including MedMen-branded assets in Santa Ana and West Hollywood. With plans to make more acquisitions in the near future, both in California and in other key markets, and significant anticipated revenue growth, there are several potential catalysts on the horizon for the company.
Stay tuned to CFN as we follow this company with good growth potential.
Please follow the link to read the full article: http://www.cannabisfn.com/captor-capital-hidden-gem-growing-quickly-attractive-cannabis-sector/
About CFN Media
CFN Media (CannabisFN) is the leading agency and financial media network dedicated to the global cannabis industry, helps companies operating in the space attract investors, capital, and publicity. Since 2013, private and public cannabis companies in the US and Canada have relied on CFN Media to grow and succeed.
Learn how to become a CFN Media client company, brand or entrepreneur: http://www.cannabisfn.com/featuredcompany
Download the CFN Media iOS mobile app to access the world of cannabis from the palm of your hand: https://itunes.apple.com/us/app/cannabisfn/id988009247?ls=1&mt=8
Or visit our homepage and enter your mobile number under the Apple App Store logo to receive a download link text on your iPhone: http://www.cannabisfn.com
CannabisFN.com is not an independent financial investment advisor or broker-dealer. You should always consult with your own independent legal, tax, and/or investment professionals before making any investment decisions. The information provided on http://www.cannabisfn.com (the ‘Site’) is either original financial news or paid advertisements drafted by our in-house team or provided by an affiliate. CannabisFN.com, a financial news media and marketing firm enters into media buys or service agreements with the companies that are the subject of the articles posted on the Site or other editorials for advertising such companies. We are not an independent news media provider. We make no warranty or representation about the information including its completeness, accuracy, truthfulness or reliability and we disclaim, expressly and implicitly, all warranties of any kind, including whether the Information is complete, accurate, truthful, or reliable. As such, your use of the information is at your own risk. Nor do we undertake any obligation to update the items posted. CannabisFN.com received compensation for producing and presenting high quality and sophisticated content on CannabisFN.com along with financial and corporate news.
The above article is sponsored content. Emerging Growth LLC, which owns CannabisFN.com and CFN Media, has been hired to create awareness. Please follow the link below to view our full disclosure outlining our compensation: http://www.cannabisfn.com/legal-disclaimer/